Related Experiment Video
Updated: Dec 22, 2025
07:19
Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain
Published on: March 24, 2023
5.8K
What is the selection process for osteoarthritis pharmacotherapy?
Shirley P Yu1,2, David J Hunter1,2
1Department of Rheumatology, Royal North Shore Hospital , Sydney, Australia.
Expert Opinion on Pharmacotherapy
|May 1, 2020
Summary
Osteoarthritis management focuses on self-care, lifestyle changes, and exercise. Current medications primarily manage pain, not disease progression, requiring individualized selection based on patient factors.
Area of Science:
- Rheumatology and Geriatric Medicine: Addressing the growing prevalence of osteoarthritis (OA) in aging and obese populations.
Background:
- Osteoarthritis is the most common joint disease, with increasing incidence linked to demographic shifts.
- Current management guidelines emphasize self-management, education, lifestyle, exercise, and weight loss.
Discussion:
- Pharmacotherapy for OA is currently limited to symptomatic pain relief.
- No available agents can prevent OA or modify its underlying disease progression.
- Individualized pharmacotherapy selection is crucial, considering patient preferences and comorbidities.
Key Insights:
- The primary goal of OA pharmacotherapy is pain palliation.
- Treatment decisions must be personalized, accounting for individual patient profiles.
- The editorial guides the selection of appropriate pain management strategies for osteoarthritis.
Outlook:
- Future research may focus on disease-modifying osteoarthritis drugs (DMOs).
- Continued emphasis on non-pharmacological interventions remains vital for comprehensive OA care.
